Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome

Behavioural Brain Research

Volumn 208, Issue 1, 2010, Pages 96-105

  Dahlhaus, Regina ^a   El Husseini, Alaa ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

FMRP; Fragile X syndrome; MRNA interactions; Neuroligin; Social behaviour; Synaptogenesis

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; NEUREXIN; NEUROLIGIN; NEUROLIGIN 1; NEUROLIGIN 2; NEUROLIGIN 3; UNCLASSIFIED DRUG; CARRIER PROTEIN; DLGH4 PROTEIN, MOUSE; FMR1 PROTEIN, MOUSE; GEPHYRIN; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; PARVALBUMIN; SIGNAL PEPTIDE; SLC17A7 PROTEIN, MOUSE; VESICULAR GLUTAMATE TRANSPORTER 1; VOLTAGE DEPENDENT ANION CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; FRAGILE X SYNDROME; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOCIAL BEHAVIOR; SOCIOPATHY; SYMPTOM; SYNAPTIC TRANSMISSION; TRANSLATION REGULATION; WESTERN BLOTTING; AGGRESSION; ANIMAL; C57BL MOUSE; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; HUMAN RELATION; MAZE TEST; METABOLISM; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PHYSIOLOGY; RECOGNITION; TRANSGENIC MOUSE; VISION;

AGGRESSION; ANIMALS; CARRIER PROTEINS; CELL ADHESION MOLECULES, NEURONAL; EXPLORATORY BEHAVIOR; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOPRECIPITATION; INTERPERSONAL RELATIONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAZE LEARNING; MEMBRANE PROTEINS; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; PARVALBUMINS; RECOGNITION (PSYCHOLOGY); RNA, MESSENGER; SOCIAL BEHAVIOR DISORDERS; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1; VISION, OCULAR; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 77951897264     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.11.019     Document Type: Article

References (81)

1. O'Donnell W.T., Warren S.T. A decade of molecular studies on the fragile X syndrome. Annu Rev Neurosci 2002, 25:3115-3138.
2. Bassell D.J., Warren S.T. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 2008, 60:201-214.
3. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 2001, 107:477-487.
4. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 2001, 107:489-499.
5. Liao L., Park S.K., Xu T., Vanderklish P., Yates Y.R. Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice. PNAS 2008, 105:15281-15286.
6. Todd P.K., Mack K.J., Malter J.S. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. PNAS 2003, 100:14374-14378.
7. Zalfa F., Eleuteri B., Dickson K.S., Mercaldo V., De Rubeis S., di Penta A., et al. A new function for the fragile X mental retardation protein in regulation of PSD-95mRNA stability. Nat Neurosci 2007, 10:578-587.
8. Muddashetty R.S., Kelic S., Gross C., Xu M., Bassell G.J. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J Neurosci 2007, 27:5338-5348.
9. Kindler S., Rehbein M., Classen B., Richter D., Boeckers T.M. Distinct spatiotemporal expression of SAPAP transcripts in the developing rat brain: a novel dendritically localized mRNA. Mol Brain Res 2004, 126:14-21.
10. Narayanan U., Nalavadi V., Nakamoto M., Pallas D.C., Ceman S., Bassell G.J., et al. FMRP phosphorylation reveals an immediate-early signalling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci 2007, 27:14349-14357.
11. Dictenberg J.B., Swanger S.A., Antar L.B., Singer R.H., Bassell G.J. A direct role for FMRP in activity dependent dendritic mRNA transport links filopodial spine morphogenesis to fragile X syndrome. Dev Cell 2008, 14:926-939.
12. Rowen L., Young J., Birditt B., Kaur A., Madan A., Philipps D.L., et al. Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics 2002, 79:587-597.
13. Tabuchi K., Südhof T.C. Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 2002, 79:849-859.
14. El-Husseini A., Schnell E., Chetkovich D.M., Nicoll R.A., Bredt D.S. PSD95 involvement in maturation of excitatory synapses. Science 2000, 290(5495):1364-1368.
15. Rao A., Harms K.J., Craig A.M. Neuroligation: building synapses around the neurexin-neuroligin link. Nat Neurosci 2000, 3(8):747-749.
16. Schnell E., Sizemore M., Karimzadegan S., Chen L., Bredt D.S., Nicoll R.A. Direct interactions between PSD95 and stargazin control synaptic AMPA receptor number. PNAS 2002, 99(1390):2-7.
17. Beique J.C., Andrade R. PSD-95 regulates synaptic transmission and plasticity in rat cerebral cortex. J Physiol 2003, 546(Pt 3):859-867.
18. Dean C., Scholl F.G., Choih J., DeMaria S., Berger J., Isacoff E., et al. Neurexin mediates the assembly of presynaptic terminals. Nat Neurosci 2003, 6(7):708-716.
19. Stein V., House D.R., Bredt D.S., Nicoll R.A. Postsynaptic density-95 mimics and occludes hippocampal long-term potentiation and enhances long-term depression. J Neurosci 2003, 23(13):5503-5506.
20. Ehrlich I., Malinow R. Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity. J Neurosci 2004, 24(4):916-927.
21. Prange O., Wong T.P., Gerrow K., Wang Y.T., El-Husseini A. A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. PNAS 2004, 101(38):13915-13920.
22. Ehrlich I., Klein M., Rumpel S., Malinow R. PSD-95 is required for activity-driven synapse stabilization. PNAS 2007, 104(10):4176-4181.
23. Futai K., Kim M.J., Hashikawa T., Scheiffele P., Sheng M., Hayashi Y. Retrograde modulation of presynaptic release probability through signalling mediated by PSD-95-neuroligin. Nat Neurosci 2007, 10(2):186-195.
24. Wittenmayer N., Körber C., Liu H., Kremer T., Varoqueaux F., Chapman E.R., et al. Postsynaptic neuroligin1 regulates presynaptic maturation. PNAS 2009, 106:13564-13569.
25. 2+ interactions. Neuron 2007, 56:992-1003.
26. Fabrichny I.P., Leone P., Sulzenbacher G., Comoletti D., Miller M.T., Taylor P., et al. Structural analysis of the synaptic protein neuroligin and its β-neurexin complex: determinants for folding and cell adhesion. Neuron 2007, 56:979-991.
27. Comoletti D., Grishaevb A., Whittenc A.E., Taylor P., Trewhellad J. Characterization of the solution structure of a neuroligin/β-neurexin complex. Chemico-Biol Interact 2008, 175:150-155.
28. Chen X., Liu H., Shim A.H.R., Focia P.J., He X. Structural basis for synaptic adhesion mediated by neuroligin-neurexin interactions. Nat Struct Mol Biol 2008, 15:50-56.
29. Comoletti D., De Jaco A., Jennings L.L., Flynn R.E., Gaietta G., Tsigelny I., et al. The Arg451Cys neuroligin-3 mutation associated with autism reveals a defect in protein processing. J Neurosci 2004, 24:4889-4893.
30. Zhang C., Milunsky J.M., Newton S., Ko J., Zhao G., Maher T.A., et al. A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J Neurosci 2009, (35):10843-10854.
31. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003, 34:27-29.
32. Ylisaukko-oja T., Rehnstrom K., Auranen M., Vanhala R., Alen R., Kempas E., et al. Analysis of four neuroligin genes as candidates for autism. Eur J Hum Genet 2005, 13(12):1285-1292.
33. Cline H. Synaptogenesis: a balancing act between excitation and inhibition. Curr Biol 2005, 15:R203-R205.
34. Südhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
35. Jamain S., Radyushkin K., Hammerschmidt K., Granon S., Boretius S., Varoqueaux F., et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. PNAS 2008, 105(5):1710-1715.
36. Lawson-Yuen A., Saldivar J.S., Sommer S., Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet 2008, 16(5):614-618.
37. Dahlhaus R, Hines RM, Eadie B, Kannangara T, Hines DJ, Brown CE, et al. Over-expression of the cell adhesion protein neuroligin-1 induces learning deficits and impairs synaptic plasticity by altering the ration of excitation to inhibition in the hippocampus. Hippocampus, in press.
38. Nadler J.J., Moy S.S., Dold G., Trang D., Simmons N., Perez A., et al. Automated apparatus for quantisation of social approach behaviours in mice. Genes Brain Behav 2004, 3:303-314.
39. Spencer C.M., Alekseyenko O., Serysheva E., Yuva-Paylor L.A., Paylor R. Altered anxiety-related and social behaviours in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav 2005, 4:420-430.
40. Mineur Y.S., Huynh L.X., Crusio W.E. Social behaviour deficits in the Fmr1 mutant mouse. Behav. Brain Res 2006, 168:172-175.
41. Arque G., Fotaki V., Fernandez D., Lagran M.M., Arbones M.L., Dierssen M. Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated Kinase 1a (Dyrk1a). PLOS One 2008, 3(7):e2575.
42. Vloeberghs E., Van Dam D., D'Hooge R., Staufenbiel M., De Deyn P.P. APP23 mice display working memory impairment in the plus-shaped water maze. Neurosci Lett 2006, 407(1):6-10.
43. Goslin K., Banker G. Experimental observations on the development of polarity by hippocampal neurons in culture. J Cell Biol 1989, 108(4):1507-1516.
44. Hines R.M., Wu L., Hines D.J., Steenland H., Mansour S., Dahlhaus R., et al. Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression. J Neurosci 2008, (24):6055-6067.
45. Song J.Y., Ichtchenko K., Südhof T.C., Brose N. Neuroligin1 is a postsynaptic cell adhesion molecule of excitatory synapses. PNAS 1999, 96:1100-1125.
46. Dresbach T., Neeb A., Meyer G., Gundelfinger E.D., Brose N. Synaptic targeting of neuroligin is independent of neurexin and SAP90/PSD95 binding. Mol Cell Neurosci 2004, 27(3):227-235.
47. Castejon O.J., Fuller L., Dailey M.E. Localisation of synapsin-1 and PSD-95 in developing postnatal rat cerebellar cortex. Brain Res Dev Brain Res 2004, 151:25-32.
48. Rosales C.R., Osborne K.D., Zuccarino G.V., Scheiffele P., Silverman M.A. A cytoplasmic motif targets neuroligin-1 exclusively to dendrites of cultured hippocampal neurons. Eur J Neurosci 2005, 22(9):2381-2386.
49. Scheiffele P., Fan J., Choih J., Fetter R., Serafini T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 2000, 101(6):657-669.
50. Bernardet M., Crusio W.E. Fmr1 KO mice as a possible model of autistic features. Scientific World J 2006, 6:1164-1176.
51. Moy S.S., Nadle J.J., Young N.B., Nonneman R.J., Grossman A.W., Murphy D.L., et al. Social approach in genetical engineered mouse lines relevant to autism. Genes Brain Behavior 2009, 8(2):129-142.
52. Mineur Y.S., Sluyter F., de Wit S., Oostra B.A., Crusio W.E. Behavioural and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 2002, 12:39-46.
53. Peier A.M., McIlwain K.L., Kenneson A., Warren S.T., Paylor R., Nelson D.L. (Over)correction of FMR1 deficiency with YAC transgenics: behavioural and physical features. Hum Mol Genet 2000, 9:1145-1159.
54. Kim J., Jung S.Y., Lee Y.K., Park S., Choi J.S., Lee C.J., et al. Neuroligin-1 is required for normal expression of LTP and associative fear memory in the amygdala of adult animals. PNAS 2008, 105(26):9087-9092.
55. Van Dam D., D'Hooge R., Hauben E., Reyniers E., Gantois I., Bakker C.E., et al. Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice. Behav Brain Res 2000, 117:127-136.
56. Yan Q.J., Asafo-Adjei P.K., Arnold H.M., Brown R.E., Bauchwitz R.P. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Genes Brain Behav 2004, 3:337-359.
57. Chih B., Gollan L., Scheiffele P. Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex. Neuron 2006, 51(2):171-178.
58. Chubykin A.A., Atasoy D., Etherton M.R., Brose N., Kavalali E.T., Gibson J.R., et al. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 2007, 54(6):919-931.
59. Gerrow K., Romorini S., Nabi S.M., Colicos M.A., Sala C., El-Husseini A. A preformed complex of postsynaptic proteins is involved in excitatory synapse development. Neuron 2006, 49:547-562.
60. Graf E.R., Zhang X., Jin S.X., Linhoff M.W., Craig A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004, 119:1013-1026.
61. Levinson J.N., Chery N., Huang K., Wong T.P., Gerrow K., Kang R., et al. Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1beta in neuroligin-induced synaptic specificity. J Biol Chem 2005, 280(17):17312-17319.
62. Nam C.I., Chen L. Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter. PNAS 2005, 102(17):6137-6142.
63. Kang Y., Zhang X., Dobie F., Wu H., Craig A.M. Induction of GABAergic postsynaptic differentiation by alpha-neurexins. J Biol Chem 2008, 283(4):2323-2334.
64. Galvez R., Greenough W.T. Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. Am J Genet 2005, 135(2):155-160.
65. Grossman A.W., Elissou N.M., McKinney B.C., Greenough W.T. Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines. Brain Res 2006, 1084:160-166.
66. Grossman A.W., Aldridge G.M., Weiler I.J., Greenough W.T. Local protein synthesis and spine morphogenesis: fragile X syndrome and beyond. J Neurosci. 2006, 26(27):7151-7155.
67. Darnell J.C., Fraser C.E., Mostovetsky O., Stefani G., Jones T.A., Eddy S.R., et al. Kissing complex RNAs mediate interaction between the fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev 2005, 19:903-918.
68. Denman R.B. Deja a vu all over again: FMRP binds U-rich target mRNAs. Biochem Biophys Res Commun 2003, 310:1-7.
69. Zou K., Liu J., Zhu N., Jin J., Liang Q., Brown W.T., et al. Identification of FMRP associated mRNAs using yeast three-hybrid system. Am J Med Genet B Neuropychiatr Genet 2008, 147b(6):769-777.
70. Bechara EG, Didiot MC, Melko M, Davidovic L, Bensaid M, Patrick M, et al. A novel function for fragile X mental retardation protein in translational activation. PLoS Biol 7 (1) (2009), e1000016. doi:10.1371/journal.pbio.1000016.
71. Bole M., Menon L., Mihailescu M.R. Fragile X mental retardation protein recognition of G quadruplex structure per se is sufficient for high affinity binding to RNA. Mol BioSyst 2008, 4:1212-1219.
72. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends Neurosci 2004, 27:370-377.
73. Feng J., Schroer R., Yan J., Song W., Yang C., Bockholt A., et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett 2006, 409:10-13.
74. Szatmari P., Paterson A.D., Zwaigenbaum L., Roberts W., Brian J., Liu X.Q., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007, 39:319-328.
75. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Faucherau F., et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007, 39:25-27.
76. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
77. Powell C. Autism as synaptopathy: animal models based on genetic mutations in trans-synaptic cell adhesion molecules. INSAR, Chicago, 8th annual international meeting for autism research, abstract 122.01; 2009.
78. Radyushkin K., Hammerschmidt K., Boretius S., Varoqueaux F., El-Kordi A., Ronnenberg A., et al. Neuroligin-3 deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behavior 2009, 8(4):416-425.
79. Blundell J., Tabuchi K., Bolliger M.F., Blaiss C.A., Brose N., Liu X., et al. Increased anxiety-like behaviour in mice lacking the inhibitory cell adhesion molecule neuroligin 2. Genes Brain Behavior 2009, 8(1):114-126.
80. Varoqueaux F., Aramuni G., Rawson R.L., Mohrmann R., Missler M., Gottmann K., et al. Neuroligins determine synapse maturation and function. Neuron 2006, 51:741-754.
81. Canty A.J., Dietze J., Harvey M., Enomoto H., Milbrandt J., Ibáñez C.F. Regionalized loss of parvalbumin interneurons in the cerebral cortex of mice with deficits in GFRalpha1 signaling. J Neurosci 2009, 29(34):10695-10705.